ProofPilot Welcomes Roslyn Schneider to Advisory Board

NEW YORK, Oct. 9, 2024 /PRNewswire/ — ProofPilot, the industry’s first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and engagement for all study stakeholders, is thrilled to announce the addition of Dr. Roslyn Schneider, Principal, RozMD Patient Affairs Consulting LLC to its Strategic Advisory Board.

Roslyn brings over 30 years of experience as a physician, biopharmaceutical executive, and consultant, known for launching blockbuster therapies and advancing patient-centered healthcare. A retired Professor of Medicine, she is a global presenter, award-winning author, and chairs the New Jersey Chapter of the American Lung Association.

“Roslyn’s deep understanding of both the pharmaceutical industry and patient-focused healthcare aligns perfectly with ProofPilot’s mission. Having worked with leading pharmaceutical companies like Pfizer, she knows firsthand the complexities of clinical trials and will help us shape solutions that meet the evolving needs of our clients,” said Chris Venezia, CEO of ProofPilot.

At ProofPilot, Roslyn will play a crucial role in advising on product direction and strategy, ensuring that the needs of patients remain at the forefront of the clinical trial process. Her expertise in patient affairs will contribute to developing innovative solutions that enhance patient engagement and recruitment, ultimately improving trial outcomes.

Roslyn Schneider stated, “Joining ProofPilot feels like a natural extension of my passion for putting patients first. I look forward to leveraging my experience to help shape strategies that not only advance clinical development but also make a real difference in patients’ lives.”

ProofPilot will continue to announce new members of its Strategic Advisory Board, ensuring its solutions deliver immediate and long-term value for all stakeholders.

About ProofPilot

ProofPilot enhances clinical trials with its Clinical Experience Platform. The StudyCoPilot platform centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience. Learn more at: https://www.proofpilot.com.

Media Contact: Colleen yang, colleen@proofpilot.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/proofpilot-welcomes-roslyn-schneider-to-advisory-board-302271559.html

SOURCE ProofPilot

Staff

Recent Posts

Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink:…

2 hours ago

Techficient Launches Surefire, Its Proprietary Modern Underwriting Engine

BOISE, Idaho, Dec. 5, 2025 /PRNewswire/ -- Techficient, a leading innovator in Insurtech solutions, announces the…

2 hours ago

Clinical Education Alliance Becomes Decera Clinical, Delivering Education, Insights, and Communications

Company brings its Scientific Activation™ mission to life at ASH Annual Meeting following November rebrand RESTON,…

2 hours ago

Shrub Oak International School Reinforces Unwavering Commitment to Student Safety and Security

MOHEGAN LAKE, N.Y., Dec. 5, 2025 /PRNewswire/ -- Shrub Oak International School today announced enhanced…

2 hours ago

‘I’D RATHER GET A ROOT CANAL’: US WORKERS DREAD THE OFFICE HOLIDAY PARTY

National poll reveals 27% of workers prefer dental work over office celebrations as workplace disconnection…

2 hours ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA…

2 hours ago